https://rheumatologydigest.org/tags/uveitis/Recent content in Uveitis on Rheumatology DigestHugoen-usSat, 06 Jun 2026 13:00:00 +0100https://rheumatologydigest.org/posts/eular-2025-behcets-syndrome/Sat, 06 Jun 2026 13:00:00 +0100https://rheumatologydigest.org/posts/eular-2025-behcets-syndrome/The 2025 EULAR update to the Behçet’s syndrome recommendations moves monoclonal TNF-alpha inhibitors (especially infliximab) to first-line induction and maintenance for eye, vascular and parenchymal-CNS disease, displacing cyclophosphamide and the azathioprine-first strategy, and broadens treatment targets to angiographic and endoscopic remission.